Advertisement

The Latest

Despite a 33 percent drop in value since the end of 2019, Globus Medical is in a position to leverage its assets and acquire companies in this depressed market, according to Benzinga.

Regenerative medicine therapies hold much potential in the orthopedic space, despite the lack of comprehensive knowledge around the therapies. Here, Anika Therapeutics interim CEO Cheryl Blanchard, PhD, explains how the company plans to approach the biologics market.

Ken Yamada on March 19 was appointed president and CEO of AxioMed, a spine device and subsidiary of private investment holding company KICVentures.

Advertisement